{"id":"NCT00496769","sponsor":"Bristol-Myers Squibb","briefTitle":"A Phase III Study of Apixaban in Patients With Atrial Fibrillation","officialTitle":"Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08-31","primaryCompletion":"2010-11-30","completion":"2017-05-25","firstPosted":"2007-07-04","resultsPosted":"2013-11-14","lastUpdate":"2018-06-15"},"enrollment":6421,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation"],"interventions":[{"type":"DRUG","name":"Apixaban","otherNames":["BMS-562247"]},{"type":"DRUG","name":"Acetylsalicylic acid","otherNames":[]}],"arms":[{"label":"Apixaban","type":"EXPERIMENTAL"},{"label":"Acetylasalicylic acid","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this clinical research study is to determine whether apixaban is more effective than acetylsalicylic acid in the prevention of strokes associated with patients with atrial fibrillation. The safety of this treatment will also be studied.","primaryOutcome":{"measure":"Event Rate of Stroke/Systemic Embolism During the Intended-treatment Period","timeFrame":"Randomization to efficacy cutoff date of May 28, 2010 (date revised following cessation of study for superior efficacy)","effectByArm":[{"arm":"Apixaban, 2.5 or 5 mg Twice Daily","deltaMin":1.62,"sd":null},{"arm":"Acetylsalicylic Acid, 81-324 mg Once Daily","deltaMin":3.63,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.00001"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":503,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Chile","China","Colombia","Czechia","Denmark","Finland","France","Germany","Greece","Hong Kong","India","Indonesia","Israel","Italy","Malaysia","Mexico","Norway","Philippines","Poland","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["35570249","35224730","31249919","26590293","23892201","23390125","23033347","22305462","21309657"],"seeAlso":["http://bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":657,"n":2798},"commonTop":["Dyspnoea","Dizziness"]}}